Intriguingly, recent reports demonstrated that GTP-binding activity of Gαh, but not transamidation, is required for the metastatic progression of breast cancer [12, 13], although Gαh expression levels are causally correlated with the metastatic potential of other cancers [14, 15]. This evidence concerns the gene GDA and breast cancer.